fda ends semaglutide shortage Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders Semaglutide shortage ends as FDA

Retatrutide dosing protocol Retatrutide uses a different titration approach, reflecting its greater potency and triple-receptor activity: Weeks 1-4: 1 mg once weekly (starting dose) Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Week 17 onward: 8-12 mg once weekly (maintenance dose) Some trial protocols use a slightly modified schedule, escalating every four weeks with dose increases of approximately double at each step

At the end of October, the FDA changed the status of all dosages of Ozempic and Wegovy to available, signaling that the end of the official shortage was likely in sight

When glucose normalizes and visceral fat decreases, you are not just altering appearance

Researchers from the Regenstrief Institute and the University of Florida analyzed data from nearly 87,000 adults participating in clinical trials conducted between 2014 and 2024